World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
45152
World Ranking
9512
National Ranking
288

Nicolas Danchin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicolas Danchin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 959 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicolas Danchin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicolas Danchin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicolas Danchin is affiliated with Université Paris Cité in France and has a research focus primarily in Medicine, with extensive contributions to Cardiology and Cardiovascular Medicine. Their work also covers Surgery, Radiology, Nuclear Medicine and Imaging, Economics and Econometrics, and Endocrinology, Diabetes and Metabolism.

The main topics addressed in their research include:

  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Heart Failure Treatment and Management
  • Coronary Interventions and Diagnostics
  • Antiplatelet Therapy and Cardiovascular Diseases

Selected recent publications by Nicolas Danchin include:

  • "Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial" (2020) published in The Lancet
  • "Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction" (2021) published in New England Journal of Medicine
  • "Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia" (2021) published in JAMA
  • "Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study" (2020) published in The Lancet Public Health
  • "Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling" (2021) published in Nature Communications

Frequent co-authors working with Nicolas Danchin include:

  • Tabassome Simon
  • Étienne Puymirat
  • Philippe Gabríel Steg
  • François Schiele
  • Yves Cottin

The most common publication venues for their research are:

  • European Heart Journal
  • Archives of cardiovascular diseases
  • Circulation
  • Archives of Cardiovascular Diseases Supplements
  • International Journal of Cardiology

Best Publications

  • Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

    Tabassome Simon;Céline Verstuyft;Murielle Mary-Krause;Lina Quteineh

  • Resting heart rate in cardiovascular disease.

    Kim Fox;Jeffrey S. Borer;A. John Camm;Nicolas Danchin

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Changing profile of infective endocarditis: results of a 1-year survey in France.

    Bruno Hoen;François Alla;Christine Selton-Suty;Isabelle Béguinot

  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials

    Mark A. Hlatky;Derek B Boothroyd;Dena M Bravata;Eric Boersma

  • Guidelines on myocardial revascularization.

    Philippe Kolh;William Wijns;Nicolas Danchin;Carlo Di Mario

  • The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004

    Lori Mandelzweig;Alex Battler;Valentina Boyko;Hector Bueno

  • Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial

    Philip A Poole-Wilson;Jacobus Lubsen;Bridget-Anne Kirwan;Fred J van Dalen

  • Darapladib for preventing ischemic events in stable coronary heart disease.

    Harvey D. White;Claes Held;Ralph Stewart;Elizabeth Tarka

  • Inhibition of the Sodium-Hydrogen Exchanger With Cariporide to Prevent Myocardial Infarction in High-Risk Ischemic Situations Main Results of the GUARDIAN Trial

    Pierre Théroux;B. R. Chaitman;N. Danchin;L. Erhardt

  • Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction.

    Etienne Puymirat;Tabassome Simon;Philippe Gabriel Steg;François Schiele

  • B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction

    Yasmine Zouggari;Hafid Ait-Oufella;Hafid Ait-Oufella;Hafid Ait-Oufella;Philippe Bonnin;Tabassome Simon

  • Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.

    Piotr Ponikowski;Bridget-Anne Kirwan;Bridget-Anne Kirwan;Stefan D Anker;Theresa McDonagh;Theresa McDonagh

  • Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015

    Etienne Puymirat;Tabassome Simon;Guillaume Cayla;Yves Cottin

  • Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).

    Nicolas Danchin;Pierre Coste;Jean Ferrières;Philippe-Gabriel Steg

  • Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy

    Y. Juillière;G. Barbier;L. Feldmann;A. Grentzinger

  • Should patients with acute coronary disease be stratified for management according to their risk?: Derivation, external validation and outcomes using the updated GRACE risk score

    Keith A. A. Fox;Gordon FitzGerald;Etienne Puymirat;Wei Huang

  • Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

    Carlos Miguel;Patrick Serruys;Peter Ruygrok;Harry Suryapranata

  • Erratum: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism (European Heart Journal (2014) 35 (3033-73) DOI 10.1093/eurheartj/ehu283)

    S. V. Konstantinides;A Torbicki;G Agnelli;N Danchin

  • C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.

    Idrissia Abdelmouttaleb;Nicolas Danchin;Claudio Ilardo;Isabelle Aimone-Gastin

Frequent Co-Authors

Tabassome Simon
Tabassome Simon Université Paris Cité
Jean Ferrières
Jean Ferrières Federal University of Toulouse Midi-Pyrénées
Bruno Pannier
Bruno Pannier Grenoble Alpes University
Ziad Mallat
Ziad Mallat University of Cambridge
Philippe Gabriel Steg
Philippe Gabriel Steg Université Paris Cité
Nicholas Moore
Nicholas Moore University of Bordeaux
Gerasimos Filippatos
Gerasimos Filippatos National and Kapodistrian University of Athens
Cédric Lemogne
Cédric Lemogne Université Paris Cité
François Alla
François Alla University of Bordeaux

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare careers beyond traditional medical school, there are multiple online pathways to explore. Many students consider adn nursing programs, which can prepare you for a nursing career in less time than a four-year degree.

For those interested in administrative roles, adn nursing programs offer streamlined training. If taking entrance exams is a concern, you may also find a nursing school that doesn't require teas or other standardized tests.

Administrative and billing careers are also accessible online. If you’re wondering, can you get financial aid for medical billing and coding? The answer is yes—many programs qualify for aid, helping to reduce costs.

For future leaders, online health administration programs are excellent choices, offering fast-track options and management-focused coursework. With so many online degrees and roles available, there’s a flexible healthcare career path for every interest.

Best Scientists Citing Nicolas Danchin

Trending Scientists

Recently Published Articles